Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Zhejiang Sanmei Chemical Industry Co Ltd (603379.SS)
CNY64.50
+0.82 (+1.29%)
CN SHH Basic Materials Chemicals - Specialty
Address
Huchu Industrial Zone 321200
Wuyi, JS, CN
Wuyi, JS, CN
CEO
Xi Xiang Hu
Website
sanmeichem.com
IPO
2019-04-09
ISIN CNE100003LM1
Description
Zhejiang Sanmei Chemical Industry Co., Ltd. engages in the research and development, production, and sales of fluorine chemical products in China and internationally. The company’s products portfolio comprises hydrofluoric acid, fluorinated refrigerant, ODS substitute products, foaming agents, and etching new materials. Zhejiang Sanmei Chemical Industry Co., Ltd. was founded in 2001 and is headquartered in Wuyi, China.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY64.50
+0.82 (+1.29%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
12M
Beta
0.68
Float Shares
219.52M
Free Float %
36.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.77% | -6.85% | -11.89% | -21.40% | +10.24% | -5.29% | +21.51% | +130.87% | +243.75% | +72.39% | +72.39% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
64.50
DCF (Unlevered)
5.98
-90.7%
DCF (Levered)
13.71
-78.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
14.04
Safe zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
5 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✓ MOAT relativo
★ Strong MOAT
-
Revenue growth Chemicals - Specialty: +4.7%+44.8% ★ Q1'26: +15.4% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+166.9% ★ Q1'26: +25.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+33.8% ★ Q1'26: +10.4% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+44.0% ★ Q1'26: +43.5% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+40.0% ★ Q1'26: +39.9% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.8% ★ Q1'26: +0.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.22× ★ Q1'26: 0.01× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.93B
est: 4.75B (-17.2%)
|
2.72B
est: 2.47B (+10.0%)
|
4.05B
est: 3.83B (+5.8%)
|
4.77B
est: 4.70B (+1.4%)
|
3.33B
est: 3.64B (-8.4%)
|
4.04B
est: 4.28B (-5.6%)
|
5.85B
est: 5.99B (-2.3%)
|
7.22B
7.15B – 7.30B
+20.7% YoY
|
7.95B
7.76B – 8.29B
+10.1% YoY
|
8.68B
8.52B – 8.92B
+9.1% YoY
|
| EBITDA |
834.17M
est: 711.45M (+17.2%)
|
304.72M
est: 370.13M (-17.7%)
|
756.40M
est: 572.62M (+32.1%)
|
552.68M
est: 704.11M (-21.5%)
|
274.71M
est: 801.89M (-65.7%)
|
1.01B
est: 943.65M (+7.6%)
|
2.72B
est: 1.32B (+106.5%)
|
1.59B
1.58B – 1.61B
+20.7% YoY
|
1.75B
1.71B – 1.83B
+10.1% YoY
|
1.91B
1.88B – 1.97B
+9.1% YoY
|
| EBIT |
746.28M
est: 569.95M (+30.9%)
|
209.25M
est: 296.51M (-29.4%)
|
659.52M
est: 458.74M (+43.8%)
|
451.44M
est: 564.08M (-20.0%)
|
160.92M
est: 700.24M (-77.0%)
|
875.72M
est: 824.03M (+6.3%)
|
2.57B
est: 1.15B (+123.3%)
|
1.39B
1.38B – 1.41B
+20.7% YoY
|
1.53B
1.49B – 1.60B
+10.1% YoY
|
1.67B
1.64B – 1.72B
+9.1% YoY
|
| Net Income |
645.91M
est: 1.20B (-46.2%)
|
221.85M
est: 239.08M (-7.2%)
|
536.17M
est: 508.81M (+5.4%)
|
485.57M
est: 557.25M (-12.9%)
|
279.64M
est: 533.64M (-47.6%)
|
778.54M
est: 788.30M (-1.2%)
|
2.06B
est: 2.08B (-1.1%)
|
2.69B
2.61B – 2.77B
+29.0% YoY
|
3.13B
2.90B – 3.36B
+16.4% YoY
|
3.63B
3.30B – 3.97B
+16.1% YoY
|
| SGA |
362.84M
est: 259.53M (+39.8%)
|
156.37M
est: 135.02M (+15.8%)
|
185.72M
est: 208.89M (-11.1%)
|
229.61M
est: 256.86M (-10.6%)
|
217.03M
est: 173.31M (+25.2%)
|
227.87M
est: 203.94M (+11.7%)
|
132.68M
est: 285.19M (-53.5%)
|
344.17M
340.47M – 347.88M
+20.7% YoY
|
378.90M
369.62M – 395.08M
+10.1% YoY
|
413.45M
406.06M – 424.76M
+9.1% YoY
|
| EPS |
1.10
est: 1.96 (-43.8%)
|
0.36
est: 0.39 (-6.8%)
|
0.88
est: 0.83 (+6.0%)
|
0.80
est: 0.91 (-12.0%)
|
0.46
est: 0.88 (-48.0%)
|
1.28
est: 1.29 (-0.7%)
|
3.40
est: 3.41 (-0.2%)
|
4.44
4.30 – 4.55
+30.4% YoY
|
5.23
4.77 – 5.53
+17.7% YoY
|
5.98
5.43 – 6.53
+14.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-28 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-27 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-26 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-25 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-22 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-21 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-20 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-19 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-14 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-29 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
1.48B
OE per share TTM
2.43
Owner's Yield
4.23%
Maintenance CapEx ratio
51.90%
Maint CapEx / Avg PPE
35.7%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 24 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF ASHS | 0.18% | 66.4K | 0.65% |
| 2 | KraneShares ICBCCS S&P China 500 Index UCITS ETF CHIN.L | 0.03% | 23.8K | 0.55% |
| 3 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.01% | 256.4K | 0.58% |
| 4 | Dimensional - Emerging Markets High Profitability ETF DEHP | 0.01% | 59.4K | 0.44% |
| 5 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.27M | 0.06% |
| 6 | Amundi Prime Emerging Markets UCITS ETF DR (C) PRAM.L | 0.00% | 67.7K | 0.10% |
| 7 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 387.5K | 0.29% |
| 8 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 23.9K | 0.44% |
| 9 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 346.2K | 0.39% |
| 10 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 96.5K | 0.26% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
1.26M
Shares Outstanding
610.48M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Cai Ling Pan | Chief Financial Officer | — | female |
| Deng Pan | Deputy General Manager | — | male |
| Lin Wei | Deputy General Manager | — | male |
| Linxi Zhan | Executive Deputy GM & Director | — | male |
| Qixiang Hu | GM & Chairman of the Board | — | male |
| Shaoming Wu | Deputy GM & Director | — | male |
| Yuchao Hu | Board Secretary | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603379.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
